\begin{table}
\caption{Efficacy under MTD constraint results.}
\label{tbl-eff}
\renewcommand{\tabcolsep}{.3em}
%\begin{center}
%\resizebox{\textwidth}{!}{%
\centering
%\begin{longtable}{lccccccc|cccccc}
%\begin{supertabular}{lccccccc|cccccc}
\begin{tabular}{lccccccc|cccccc}
%
%\toprule
    Algorithm &  E-Stop 
    &\multicolumn{6}{c}{ Recommended} & \multicolumn{6}{c}{Allocated} \\
    \hline
    & & 1 & 2 &  3 & 4 & 5 & 6 & 1 & 2 & 3 &  4 &  5 &  6 \\
\hline
%\endfirsthead
%%
%&\multicolumn{12}{c}%
%{{\bfseries \tablename\ \thetable{} -- continued from previous page}} \\
%%\toprule
%\hline
%    Algorithm &  E-Stop 
%    &\multicolumn{6}{c}{ Recommended} & \multicolumn{6}{c}{Allocated} \\
%    \hline
%    & &   1 &   2 & 3 &   4 &   5 &   6 &  1 &  2 & 3 &  4 &  5 &  6 \\
%    \hline
%\endhead
%%
%\hline \multicolumn{12}{r}{\textit{Continued on next page}} \\
%\endfoot
%%
%\hline
%\endlastfoot
%&\multicolumn{12}{c}{Scenario 1} & \\
%\hline
\multicolumn{2}{l}{\textbf{Sc. 1:} Toxicity probabilities} & 0.01  & 0.05 & \underline{0.15} & 0.2 & 0.45 & 0.6  &  0.01  & 0.05 & \underline{0.15} & 0.2 & \dash{0.45} & \dash{0.6} \\ 
\multicolumn{2}{l}{\textbf{Sc. 1:} Efficacy probabilities}  & 0.1 & 0.35 & \underline{0.6} & 0.6 & 0.6 & 0.6 &  0.1 & 0.35 & \underline{0.6} & 0.6 & 0.6 & 0.6 \\ 
\hline     
       $\mathrm{MTA}$-$\mathrm{RA}$ &      0.4 &  0.4 &  7.0 &  \tblopt{54.9} &  29.1 &  7.4 &  0.7 &   7.1 &   14.2 &  \tblopt{37.9} &   24.9 &   \dash{12.9} &   \dash{2.5} \\
       $\mathrm{TS}$ &      0.9 &  0.1 &  9.7 &  \tblwinrec{\tblopt{57.7}} &  27.0 &  4.2 &  0.4 &   10.6 &   18.4 &  \tblopt{31.9} &   23.8 &   10.0 &   4.4 \\
     $\mathrm{TS}\_\mathrm{A}$ &      0.9 &  0.3 &  9.6 &  \tblwinrec{\tblopt{59.4}} &  26.1 &  3.5 &  0.3 &   10.7 &   20.7 &  \tblopt{35.7} &   23.9 &   \dash{7.3} &   \dash{0.9} \\
\hline
%&\multicolumn{12}{c}{Scenario 2} & \\
%\hline
\multicolumn{2}{l}{\textbf{Sc. 2:} Toxicity probabilities}& 0.005  & 0.01 & 0.02 & 0.05 & \underline{0.1} & 0.15 & 0.005  & 0.01 & 0.02 & 0.05 & \underline{0.1} & 0.15\\  
\multicolumn{2}{l}{\textbf{Sc. 2:} Efficacy probabilities} &  0.001  & 0.1 & 0.3 & 0.5 & \underline{0.8} & 0.8 &  0.001  & 0.1 & 0.3 & 0.5 & \underline{0.8} & 0.8\\
 \hline
       $\mathrm{MTA}$-$\mathrm{RA}$ &      1.9 &  0.0 &  0.1 &  1.6 &  05.1 &  \tblopt{55.0} &  36.2 &   5.2 &   5.6 &   7.5 &   11.4 &  \tblopt{36.7} &   31.7 \\
       $\mathrm{TS}$ &      0.7 &  0.0 &  0.0 &  0.5 &  4.6 &  \tblwinrec{\tblopt{56.6}} &  37.4 &   5.9 &   6.6 &   9.3 &   16.9 &  \tblopt{32.5} &   28.1 \\
    $\mathrm{TS}\_\mathrm{A}$ &      2.2 &  0.0 &  0.1 &  1.6 &  5.0 &  \tblwinrec{\tblopt{55.8}} &  35.2 &   5.9 &   6.8 &   10.9 &   17.9 &  \tblopt{31.8} &   24.5 \\
\hline
%&\multicolumn{12}{c}{Scenario 3} & \\
%\hline
\multicolumn{2}{l}{\textbf{Sc. 3:} Toxicity probabilities}  & \underline{0.01}  & 0.05 & 0.1 & 0.25 & 0.5 & 0.7 & \underline{0.01}  & 0.05 & 0.1 & 0.25 & \dash{0.5} & \dash{0.7}\\ 
\multicolumn{2}{l}{\textbf{Sc. 3:} Efficacy probabilities}  & \underline{0.4}  & 0.4 & 0.4 & 0.4 & 0.4 & 0.4 & \underline{0.4}  & 0.4 & 0.4 & 0.4 & 0.4 & 0.4 \\ 
\hline
       $\mathrm{MTA}$-$\mathrm{RA}$ &      0.4 &  \tblopt{51.5} &  26.4 &  12.5 &  6.8 &  2.2 &  0.2 &  \tblopt{38.2} &   24.8 &   16.6 &   12.9 &   \dash{6.1} &   \dash{0.9} \\
       $\mathrm{TS}$ &      0.1 &  \tblwinrec{\tblopt{53.9}} &  24.8 &  12.1 &  7.9 &  1.1 &  0.2 &  \tblopt{24.1} &   22.7 &   23.8 &   19.0 &   7.2 &   3.1 \\
    $\mathrm{TS}\_\mathrm{A}$ &      0.5 &  \tblwinrec{\tblopt{53.7}} &  26.4 &  10.4 &  8.2 &  0.7 &  0.1 &  \tblopt{26.6} &   25.1 &   24.8 &   17.7 &   \dash{4.8} &   \dash{0.5} \\
\hline
%&\multicolumn{12}{c}{Scenario 4} & \\
%\hline
\multicolumn{2}{l}{\textbf{Sc. 4:} Toxicity probabilities} & 0.01  & 0.02 & \underline{0.05} & 0.1 & 0.2 & 0.3 & 0.01  & 0.02 & \underline{0.05} & 0.1 & 0.2 & 0.3 \\ 
\multicolumn{2}{l}{\textbf{Sc. 4:} Efficacy probabilities}  & 0.25  & 0.45 & \underline{0.65} & 0.65 & 0.65 & 0.65 & 0.25  & 0.45 & \underline{0.65} & 0.65 & 0.65 & 0.65 \\
\hline
       $\mathrm{MTA}$-$\mathrm{RA}$ &      0.2 &  1.8 &  13.2 &  \tblopt{49.0} &  21.7 &  8.5 &  5.7 &   9.5 &   17.7 &  \tblopt{31.6} &   20.6 &   13.9 &   6.6 \\
       $\mathrm{TS}$ &      0.2 &  1.8 &  15.7 &  \tblopt{45.8} &  18.0 &  10.8 &  7.8 &   12.1 &   16.8 &  \tblopt{23.1} &   21.6 &   16.5 &   9.8 \\
    $\mathrm{TS}\_\mathrm{A}$ &      0.2 &  2.4 &  15.0 &  \tblwinrec{\tblopt{49.1}} &  20.3 &  9.8 &  3.3 &   13.2 &   19.3 &  \tblopt{25.5} &   21.8 &   14.1 &   5.8 \\
\hline
%&\multicolumn{12}{c}{Scenario 5 (plateau occuring for large toxicities)} & \\
%\hline
\multicolumn{2}{l}{\textbf{Sc. 5:} Toxicity probabilities} & 0.1  & 0.2 & \underline{0.25} & 0.4 & 0.5 & 0.6 & 0.1  & 0.2 & 0.25 & \dash{0.4} & \dash{0.5} & \dash{0.6} \\ 
\multicolumn{2}{l}{\textbf{Sc. 5:} Efficacy probabilities} &   0.3  & 0.4 & \underline{0.5} & 0.7 & 0.7 & 0.7 & 0.3  & 0.4 & 0.5 & 0.7 & 0.7 & 0.7 \\ 
\hline
       $\mathrm{MTA}$-$\mathrm{RA}$ &      1.4 &  \underline{9.0} &  13.3 &  25.9 &  40.6 &  8.3 &  1.5 &   15.5 &   19.1 &  24.9 &   \dash{26.7} &   \dash{9.9} &   \dash{2.4} \\
       $\mathrm{TS}$ &      5.8 &  8.4 &  24.4 &  \tblwinrec{\underline{40.0}} &  18.9 &  2.4 &  0.3 &   20.8 &   27.3 &  24.4 &   13.0 &   5.5 &   3.3 \\
    $\mathrm{TS}\_\mathrm{A}$ &      6.9 &  16.7 &  30.6 &  \tblwinrec{\underline{30.6}} &  14.4 &  0.8 &  0.0 &   25.9 &   33.8 &  22.8 &   \dash{8.6} &   \dash{1.8} &   \dash{0.2} \\
\hline
%&\multicolumn{12}{c}{Scenario 6 (plateau occuring for large toxicities)} & \\
%\hline
\multicolumn{2}{l}{\textbf{Sc. 6:} Toxicity probabilities} & 0.1  & 0.3 & \underline{0.35} & 0.4 & 0.5 & 0.6 & 0.1  & 0.3 & \underline{0.35} & \dash{0.4} & \dash{0.5} & \dash{0.6} \\ 
\multicolumn{2}{l}{\textbf{Sc. 6:} Efficacy probabilities} &   0.3  & 0.4 & \underline{0.5} & 0.7 & 0.7 & 0.7 &   0.3  & 0.4 & \underline{0.5} & 0.7 & 0.7 & 0.7 \\ 
\hline
       $\mathrm{MTA}$-$\mathrm{RA}$ & 4.3 &  11.2 &  24.3 &  \underline{24.6} &  28.9 &  5.4 &  1.3 &   17.9 &  24.2 &   \underline{23.7} &   \dash{20.7} &   \dash{7.7} &   \dash{1.7} \\
       $\mathrm{TS}$ &      8.4 &  17.8 &  41.9 &  \underline{22.5} &  8.1 &  1.1 &  0.3 &   29.6 &  30.4 &   \underline{16.9} &   8.3 &   4.0 &   2.4 \\
    $\mathrm{TS}\_\mathrm{A}$ &      9.4 &  28.5 &  43.6 &  \underline{14.2} &  4.0 &  0.3 &  0.0 &   34.5 &  37.2 &   \underline{14.3} &   \dash{3.9} &   \dash{0.6} &   \dash{0.1} \\
\hline
%&\multicolumn{12}{c}{Scenario 7 (quasi-plateau)} & \\
%\hline
\multicolumn{2}{l}{\textbf{Sc. 7:} Toxicity probabilities} & 0.03  & \underline{0.06} & 0.1 & 0.2 & 0.4 & 0.5 & 0.03  & \underline{0.06} & 0.1 & 0.2 & \dash{0.4} & \dash{0.5} \\ 
\multicolumn{2}{l}{\textbf{Sc. 7:} Efficacy probabilities} & 0.3  & \underline{0.5} & 0.52 & 0.54 & 0.55 & 0.55 &  0.3  & \underline{0.5} & 0.52 & 0.54 & 0.55 & 0.55 \\ 
\hline 
       $\mathrm{MTA}$-$\mathrm{RA}$ &      0.1 &  8.6 &  \tblopt{45.5} &  25.1 &  13.7 &  5.7 &  1.3 &   16.1 &  \tblopt{31.5} &   22.8 &   17.0 &   \dash{9.9} &   \dash{2.5} \\
       $\mathrm{TS}$ &      0.7 &  10.3 &  \tblopt{43.7} &  22.2 &  16.3 &  5.7 &  1.2 &   17.5 &  \tblopt{22.7} &   23.2 &   20.6 &   10.3 &   4.9 \\
    $\mathrm{TS}\_\mathrm{A}$ &      0.4 &  11.4 &  \tblwinrec{\tblopt{47.8}} &  22.8 &  13.3 &  4.2 &  0.2 &   19.8 &  \tblopt{26.9} &   26.1 &   19.0 &   \dash{6.6} &   \dash{1.2} \\
\hline
%&\multicolumn{12}{c}{Scenario 8 (quasi-plateau)} & \\
%\hline
\multicolumn{2}{l}{\textbf{Sc. 8:} Toxicity probabilities} & 0.02  & 0.07 & \underline{0.13} & 0.17 & 0.25 & 0.3 & 0.02  & 0.07 & \underline{0.13} & 0.17 & 0.25 & 0.3\\ 
\multicolumn{2}{l}{\textbf{Sc. 8:} Efficacy probabilities}  & 0.3  & 0.5 & \underline{0.7} & 0.73 & 0.76 & 0.77 & 0.3  & 0.5 & \underline{0.7} & 0.73 & 0.76 & 0.77 \\
      \hline
       $\mathrm{MTA}$-$\mathrm{RA}$ &      0.1 &  1.1 &  10.2 &  \tblopt{39.0} &  24.4 &  16.8 &  8.4 &   9.3 &   15.8 &  \tblopt{28.8} &   22.6 &   15.7 &   7.8 \\
       $\mathrm{TS}$ &      0.3 &  1.3 &  11.1 &  \tblopt{36.8} &  24.2 &  16.1 &  10.2 &   12.1 &   17.4 &  \tblopt{24.1} &   21.9 &   15.0 &   9.1 \\
    $\mathrm{TS}\_\mathrm{A}$ &      0.3 &  1.8 &  13.2 &  \tblwinrec{\tblopt{45.6}} &  24.1 &  11.4 &  3.7 &   14.2 &   22.2 &  \tblopt{28.6} &   21.0 &   10.3 &   3.4 \\
\hline
\end{tabular}
\end{table}				
%
%
%
%
\begin{table}
\caption{Efficacy under MTD constraint results (continued).}
\label{tbl-eff-b}
\renewcommand{\tabcolsep}{.3em}
%\begin{center}
%\resizebox{\textwidth}{!}{%
\centering
%\begin{longtable}{lccccccc|cccccc}
%\begin{supertabular}{lccccccc|cccccc}
\begin{tabular}{lccccccc|cccccc}
%
%\toprule
    Algorithm &  E-Stop 
    &\multicolumn{6}{c}{ Recommended} & \multicolumn{6}{c}{Allocated} \\
    \hline
    & & 1 & 2 &  3 & 4 & 5 & 6 & 1 & 2 & 3 &  4 &  5 &  6 \\
\hline
%
%&\multicolumn{12}{c}{Scenario 9 (no plateau, one acceptable dose with low efficacy)} & \\
%\hline
\multicolumn{2}{l}{\textbf{Sc. 9:} Toxicity probabilities} & 0.25  & 0.43 & 0.50 & 0.58 & 0.64 & 0.75 & \underline{0.25}  & \dash{0.43} & \dash{0.50} & \dash{0.58} & \dash{0.64} & \dash{0.75} \\ 
\multicolumn{2}{l}{\textbf{Sc. 9:} Efficacy probabilities}  & 0.3  & 0.4 & 0.5 & 0.6 & 0.61 & 0.63 & 0.3  & \underline{0.4} & 0.5 & 0.6 & 0.61 & 0.63 \\ 
\hline
       $\mathrm{MTA}$-$\mathrm{RA}$ &      18.8 &  40.0 &  33.2 &  7.0 &  0.9 &  0.1 &  0.1 &  {32.0} &   \dash{30.3} &   \dash{13.6} &  \dash{4.3} &   \dash{1.0} &   \dash{0.1} \\
       $\mathrm{TS}$ &      \tblwinrec{49.0} &  \tblwinrec{{37.3}} &  12.4 &  1.1 &  0.2 &  0.0 &  0.0 &  {29.0} &   13.7 &   4.5 &   1.9 &   1.1 &   0.8 \\
    $\mathrm{TS}\_\mathrm{A}$ &      \tblwinrec{50.5} &  \tblwinrec{{39.8}} &  9.1 &  0.5 &  0.1 &  0.0 &  0.0 &  {31.2} &   \dash{14.6} &   \dash{3.3} &   \dash{0.4} &   \dash{0.0} &   \dash{0.0} \\
\hline
%&\multicolumn{12}{c}{Scenario 10 (no plateau, no acceptable dose)} & \\
%\hline
\multicolumn{2}{l}{\textbf{Sc. 10:} Toxicity probabilities} & 0.05  & 0.1 & 0.25 & 0.55 & 0.7 & 0.9 & 0.05  & 0.1 & 0.25 & \dash{0.55} & \dash{0.7} & \dash{0.9} \\ 
\multicolumn{2}{l}{\textbf{Sc. 10:} Efficacy probabilities} & 0.01  & 0.02 & 0.05 & 0.35 & 0.55 & 0.7 & 0.01  & 0.02 & 0.05 & 0.35 & 0.55 & 0.7 \\ 
\hline 
       $\mathrm{MTA}$-$\mathrm{RA}$ &      91.7 &  0.5 &  0.5 &  2.3 &  4.8 &  0.1 &  0.0 &   0.6 &   0.7 &  1.3 &   \dash{4.4} &   \dash{1.1} &   \dash{0.2} \\
       $\mathrm{TS}$ &      61.9 &  12.1 &  2.5 &  1.8 &  19.7 &  1.8 &  0.1 &   3.8 &   8.9 &  16.3 &   6.3 &   1.9 &   0.9 \\
    $\mathrm{TS}\_\mathrm{A}$ &      \tblwinrec{94.1} &  0.2 &  0.1 &  1.3 &  4.3 &  0.1 &  0.0 &   0.5 &   0.6 &  1.4 &   \dash{2.9} &   \dash{0.5} &   \dash{0.0} \\
\hline
%&\multicolumn{12}{c}{Scenario 11 (plateau, no acceptable dose)} & \\
%\hline
\multicolumn{2}{l}{\textbf{Sc. 11:} Toxicity probabilities} & 0.5  & 0.6 & 0.69 & 0.76 & 0.82 & 0.89 & \dash{0.5}  & \dash{0.6} & \dash{0.69} & \dash{0.76} & \dash{0.82} & \dash{0.89} \\ 
\multicolumn{2}{l}{\textbf{Sc. 11:} Efficacy probabilities} & 0.4  & 0.55 & 0.65 & 0.65 & 0.65 & 0.65 & 0.4  & 0.55 & 0.65 & 0.65 & 0.65 & 0.65 \\ 
\hline
       $\mathrm{MTA}$-$\mathrm{RA}$ &      90.1 &  9.6 &  0.3 &  0.1 &  0.0 &  0.0 &  0.0 &   \dash{7.2} &   \dash{2.0} &   \dash{0.5} &   \dash{0.1} &   \dash{0.0} &   \dash{0.0} \\
       $\mathrm{TS}$ &      \tblwinrec{99.8} &  0.2 &  0.0 &  0.0 &  0.0 &  0.0 &  0.0 &   0.1 &   0.1 &   0.0 &   0.0 &   0.0 &   0.0 \\
    $\mathrm{TS}\_\mathrm{A}$ &      \tblwinrec{99.5} &  0.5 &  0.0 &  0.0 &  0.0 &  0.0 &  0.0 &   \dash{0.4} &   \dash{0.1} &   \dash{0.0} &   \dash{0.0} &   \dash{0.0} &   \dash{0.0} \\
%
\hline
\multicolumn{2}{l}{\textbf{Sc. 12:} Toxicity probabilities}  & $0.01$  & $0.02$ & $0.05$ & $\underline{0.1}$ & $0.25$ & $0.5$  & $0.01$  & $0.02$ & $0.05$ & $\underline{0.1}$ & $0.25$ & \dash{$0.5$} \\ 
\multicolumn{2}{l}{\textbf{Sc. 12:} Efficacy probabilities} & $0.05$  & $0.25$ & $0.45$ & $\underline{0.7}$ & $0.7$ & $0.7$ & $0.05$  & $0.25$ & $0.45$ & $\underline{0.7}$ & $0.7$ & \dash{$0.7$} \\
\hline 
       $\mathrm{MTA}$-$\mathrm{RA}$ &      1.0 &  0.2 &  1.3 &  8.9 &  \tblopt{52.8} &  29.4 &  6.4 &   5.8 &   7.6 &   14.6 &  \tblopt{35.9} &   24.9 &   \dash{10.2} \\
       $\mathrm{TS}$ &      0.7 &  0.0 &  0.6 &  10.0 &  \tblwinrec{\tblopt{57.0}} &  27.7 &  4.0 &   7.7 &   10.4 &   17.9 &  \tblopt{32.2} &   21.9 &   9.3 \\
    $\mathrm{TS}\_\mathrm{A}$ &      1.7 &  0.0 &  1.3 &  10.0 &  \tblwinrec{\tblopt{56.0}} &  26.8 &  4.2 &   7.5 &   11.3 &   19.5 &  \tblopt{32.1} &   21.6 &   \dash{6.4} \\
\hline
\multicolumn{2}{l}{\textbf{Sc. 13:} Toxicity probabilities}  & $0.01$  & $0.05$ & $0.1$ & $0.2$ & $\underline{0.3}$ & $0.5$  & $0.01$  & $0.05$ & $0.1$ & $0.2$ & $\underline{0.3}$ & $0.5$ \\
\multicolumn{2}{l}{\textbf{Sc. 13:} Efficacy probabilities}  & $0.05$  & $0.1$ & $0.2$ & $0.35$ & $\underline{0.55}$ & $0.55$ & $0.05$  & $0.1$ & $0.2$ & $0.35$ & $\underline{0.55}$ & $0.55$ \\
\hline 
       $\mathrm{MTA}$-$\mathrm{RA}$ &      14.9 &  0.7 &  1.8 &  5.6 &  17.0 &  \tblopt{50.3} &  9.7 &   6.4 &   7.4 &   11.1 &   18.7 &  \tblopt{30.7} &   \dash{10.8} \\
       $\mathrm{TS}$ &      8.6 &  0.5 &  1.8 &  6.7 &  37.7 &  \tblopt{39.0} &  5.6 &   9.1 &   11.5 &   17.5 &   26.3 &  \tblopt{18.6} &   8.4 \\
    $\mathrm{TS}\_\mathrm{A}$ &      17.3 &  0.5 &  1.3 &  7.4 &  31.6 &  \tblopt{37.5} &  4.3 &   7.2 &   9.1 &   16.7 &   26.8 &  \tblopt{18.1} &   \dash{4.7} \\
\hline
\end{tabular}
%\end{longtable}
%\end{supertabular}
%}%resizebox
%\end{center}
\end{table}				
